Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Healthtrust
Chinese Patent Office
Chubb
Express Scripts
Cipla
Julphar
Fish and Richardson

Generated: June 19, 2018

DrugPatentWatch Database Preview

NUROMAX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Nuromax, and what generic alternatives are available?

Nuromax is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in NUROMAX is doxacurium chloride. Additional details are available on the doxacurium chloride profile page.
Summary for NUROMAX
Drug patent expirations by year for NUROMAX
Synonyms for NUROMAX
(1R,2S,1'S,2'R)-2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl)]bis[2-methyl-6,7,8-tris(methyloxy)-1-{[3,4,5-tris(methyloxy)phenyl]methyl}-1,2,3,4-tetrahydroisoquinolinium] dichloride
(1R,2S,1'S,2'R)-2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl)]bis[6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium] dichloride
(1R,2S;1S,2R)-1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium chloride, succinate (2:1)
(1R,2S;1S,2R)-1,2,3,4-Tetrahydro-2-(3-hydroxypropyl)-6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium chloride, succinate (2:1), mixture with (+-)-(1R*,2S*;1R*,2S*)-1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7
1-O-[3-[(1R,2S)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 4-O-[3-[(1S,2R)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinoli
1-O-[3-[(1R)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 4-O-[3-[(1S)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-iu
106819-53-8
AC1L1SOT
AC1NR4NV
AC1NSJYB
AC1Q1RPW
AN-5620
Bis[3-[6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)
bis[3-[6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] butanedioate dichloride
BW A938U dichloride
BW-A 938U
BW-A938U
BW-A938U Dichloride
CHEBI:59819
CHEMBL1237099
Chlorure de doxacurium
Cloruro de doxacurio
D00760
DB01135
DOXACURIUM CHLORIDE
Doxacurium chloride (USAN/INN)
Doxacurium chloride [USAN:INN:BAN]
doxacurium chloride(no stereochemistry)
DTXSID7022962
HE293479
meso-doxacurium chloride
MN728NK085
Nuromax (TN)
SCHEMBL1649198
SCHEMBL41319
UNII-M78TVM3G5Z component APADFLLAXHIMFU-LGIHQUBZSA-L
UNII-MN728NK085

US Patents and Regulatory Information for NUROMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie NUROMAX doxacurium chloride INJECTABLE;INJECTION 019946-001 Mar 7, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Chinese Patent Office
Boehringer Ingelheim
UBS
McKinsey
AstraZeneca
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.